Weaver Consulting Group Moderna, Inc. Transaction History

Weaver Consulting Group

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$225.82 - $368.51 $138,653 - $226,265	-614 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$221.9 - $484.47 $136,246 - $297,464	614 New	614 $236,000
Q4 2020 Jan 29, 2021	SELL	$65.74 - $169.86 $47,464 - $122,638	-722 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$54.34 - $94.85 $1,412 - $2,466	-26 Reduced 3.48%	722 $51,000
Q2 2020 Jul 24, 2020	BUY	$29.67 - $80.0 $22,193 - $59,840	748 New	748 $48,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

Stay updated on Weaver Consulting Group with notifications on news.